NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Total Non-Current Liabilities (2021 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Total Non-Current Liabilities came in at $72000.0 in Q4 2025, up 100.0% quarter-over-quarter from $36000.0 in Q2 2024.

Analysis

NeuroSense Therapeutics (NRSN) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $72000.0 for Q4 2025.

  • In Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $72000.0; the TTM figure through Dec 2025 stood at $72000.0 (changed N/A YoY), while the FY2025 annual figure was $72000.0, changed N/A from the prior year.
  • Total Non-Current Liabilities came in at $72000.0 for Q4 2025 at NeuroSense Therapeutics, up from $36000.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $6.4 million in Q2 2023 to a low of $36000.0 in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $1.6 million, with a median of $881000.0 recorded in 2022.
  • Year-over-year, Total Non-Current Liabilities jumped 910.2% in 2023 and slumped 99.44% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $1.8 million in 2021, then tumbled by 91.96% to $147000.0 in 2022, then jumped by 910.2% to $1.5 million in 2023, then tumbled by 97.58% to $36000.0 in 2024, then soared by 100.0% to $72000.0 in 2025.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $72000.0 in Q4 2025, $36000.0 in Q2 2024, and $1.5 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 81.11 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 36.04 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 5.92 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 7.74 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 3.92 Bn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 40.00 Mn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 12.42 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 378.37 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 72,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 72,000.00
Jun 30, 2024 36,000.00
Dec 31, 2023 1.49 Mn
Jun 30, 2023 6.41 Mn
Dec 31, 2022 147,000.00
Jun 30, 2022 881,000.00
Dec 31, 2021 1.83 Mn
API Access

NeuroSense Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NRSN&period=max&api_key=YOUR_API_KEY